Literature DB >> 28795831

Problem-solving therapy for suicide prevention in veterans with moderate-to-severe traumatic brain injury.

Sean M Barnes1, Lindsey L Monteith1, Georgia R Gerard1, Adam S Hoffberg1, Beeta Y Homaifar1, Lisa A Brenner1.   

Abstract

OBJECTIVE: Develop and test the acceptability and feasibility of Problem-Solving Therapy for Suicide Prevention (PST-SP), a group intervention aimed at improving problem solving and preventing suicide, among Veterans with hopelessness and moderate-to-severe traumatic brain injury (TBI). RESEARCH
METHOD: Following treatment development, 16 U.S. Veterans with moderate-to-severe TBI and a Beck Hopelessness Scale score ≥4 participated in an acceptability and feasibility pilot study of PST-SP at a Veterans Affairs Medical Center. Participants completed the Client Satisfaction Questionnaire-8 (CSQ-8) and Narrative Evaluation of Intervention Interview (NEII) after participating in PST-SP.
RESULTS: PST-SP was developed for Veterans with moderate-to-severe TBI and hopelessness. 75% (n = 12) of participants enrolled in the pilot study attended ≥80% of PST-SP sessions. Participants reported high satisfaction with PST-SP (CSQ-8 M = 27.8 out of 32; SD = 4.78; range 14-32) and described the intervention as valuable, beneficial, and without negative effects (NEII). CONCLUSIONS/IMPLICATIONS: Results from measures of acceptability and attendance suggest that PST-SP is an acceptable and feasible intervention for Veterans with hopelessness and moderate-to-severe TBI. Findings support readiness to examine efficacy of the intervention in a Phase II randomized controlled trial. (PsycINFO Database Record (c) 2017 APA, all rights reserved).

Entities:  

Mesh:

Year:  2017        PMID: 28795831     DOI: 10.1037/rep0000154

Source DB:  PubMed          Journal:  Rehabil Psychol        ISSN: 0090-5550


  1 in total

1.  Challenges Associated with the Use of Policy to Identify and Manage Risk for Suicide and Interpersonal Violence Among Veterans and Other Americans.

Authors:  Robert M Bossarte
Journal:  Adm Policy Ment Health       Date:  2018-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.